Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Glioma × Carboplatin × Clear all

Phase

Phase 2 9 Phase 1/2 6 Phase 1 6 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Lymphoma, B-Cell 1 Head and Neck Neoplasms 1 Glioma 1 Fallopian Tube Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 fluciclovine F-18 4 Temozolomide 4 Radiotherapy 4 fluorodopa F 18 3 Topotecan 3 niraparib 2 abemaciclib 2 Standard of Care 2 Specimen Handling 2 Pemetrexed 2 Ketoconazole 2 Biopsy 2 ulixertinib 1 temsirolimus 1 ribociclib 1 posaconazole 1 poly ICLC 1 pembrolizumab 1 orludodstat 1 lorlatinib 1 larotrectinib 1 infigratinib 1 fisetin 1 fimepinostat 1 evolocumab 1 clevudine 1 X-Rays 1 Watchful Waiting 1 Vardenafil Dihydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02279992 2017-09-11

LevitraCarbo

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡